Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2
about
Vaccines for gonorrhea: can we rise to the challenge?Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseExpression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter.Review of meningococcal group B vaccines.Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from AfricaModulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutantsThe effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood.Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine developmentCooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccinesA native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis.Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.Identification of a phage-encoded Ig-binding protein from invasive Neisseria meningitidis.A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity.Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.The epidemiology of meningococcal disease and the impact of vaccines.Bioanalysis of meningococcal vaccines.Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?Neisseria meningitidis B vaccines: recent advances and possible immunization policies.Biosynthetically engineered lipopolysaccharide as vaccine adjuvant.Meningococcal serogroup B vaccines: will they live up to expectations?Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation.Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales
P2860
Q21131153-2B5660EA-9650-4DD4-AC3F-36733B4C92ECQ26995760-C91C5FF5-6FB8-4299-AD2A-F00B8CF0BB70Q33614888-101B4844-E59D-4707-88B7-E5B5DCF0DC73Q33646965-D2E3B85F-3821-46F0-A046-0E599694181DQ34039044-300C8AEC-CA5A-4D5E-92FC-E0A38D70899DQ34138990-BB7CEEDF-93CC-4B32-A0A1-EDF3F0F0D66CQ34270429-B050E5BE-C1FF-4709-86B9-C356FCF96DCAQ34484616-30E7B5E9-2C69-41DE-8004-DF7D7D4FAB3DQ34571107-A6007188-8DFB-4D24-8CAA-0F66C2E5ADDEQ34594327-8158F29A-B2C9-460B-BAA4-1F319012C222Q34761285-B4332827-C7B1-49DA-990E-AAC0D70A50E8Q34785389-3A0475EB-05B1-4895-AB39-5F97E31775BAQ35043042-6949960B-C3CD-423F-8A20-8E096C80438AQ35066132-7FD825DA-F17B-4D1E-94B3-926CD7158D86Q35181636-4AC22341-C270-4772-9312-EF7E0FC42191Q35198778-8D9D044E-1537-43A6-B7A5-72D7EF0B9D07Q35989852-B4B9C065-B5E3-431D-94D1-D9577A6B0A2FQ36354851-B4B17C74-9F00-43A5-AF66-68CDBBEA4058Q36764359-B3B4A05D-C188-4345-B473-57D171CC9583Q37002310-C031D1CA-DEDE-4E2F-97A0-D08D9E6D9D27Q37163679-B773C378-98D8-4D99-B4AD-92F44B925085Q37191264-3563E445-1973-45CB-B607-C5EC0B7835FBQ37483629-1675E9C3-C1EB-40CC-BE70-2B8B0A470DFAQ37545048-51ED886C-F5D4-49CB-833D-644815F6F52FQ37706585-CF3A2E3C-4D73-42A6-AF0E-C5BDF03FB005Q37810253-7F69D4CB-4B00-4AB0-A3D6-D0853A8E1461Q37857249-1B422F2F-A65A-4633-9106-057BE54ADB1EQ38132262-C857EF6E-3412-4B76-980C-4CFC596ECA25Q38183156-C354C6E1-8ECC-486A-ADB4-85A9DBEEF868Q38386726-BD57F2E3-0F0C-4727-9AB0-82615ECEEA32Q38726967-5364BFF3-4485-4CBA-A9FC-503570A66475Q39418716-8D353B1F-EBA6-46D6-B06E-3943809B6DAAQ41845489-98D9DFDB-8EC5-4448-8E7D-8ECFEABE75C3
P2860
Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meningococcal outer membrane v ...... tigenic variant groups 1 and 2
@en
Meningococcal outer membrane v ...... igenic variant groups 1 and 2.
@nl
type
label
Meningococcal outer membrane v ...... tigenic variant groups 1 and 2
@en
Meningococcal outer membrane v ...... igenic variant groups 1 and 2.
@nl
prefLabel
Meningococcal outer membrane v ...... tigenic variant groups 1 and 2
@en
Meningococcal outer membrane v ...... igenic variant groups 1 and 2.
@nl
P2093
P2860
P356
P1476
Meningococcal outer membrane v ...... tigenic variant groups 1 and 2
@en
P2093
Dan M Granoff
Oliver Koeberling
Serena Giuntini
P2860
P304
P356
10.1128/CVI.00403-08
P50
P577
2008-12-24T00:00:00Z